Table 1 Baseline characteristics of 116 Japanese patients with RA
Characteristics | Value |
|---|---|
Age (years), median (IQR) | 66 (56–73) |
Female, n (%) | 83 (71.6) |
Smoker, n (%) | 44 (37.9) |
RA-ILD, n (%) | 31 (26.7) |
Duration of RA (year), median (IQR) | 5 (2–10) |
ESR (mm/h), median (IQR) | 15.5 (7–27) |
CRP (mg/dL), median (IQR) | 0.29 (0.09–0.9) |
MMP-3 (ng/mL), median (IQR) | 106 (61.8–207.3) |
RF (IU/mL), median (IQR) | 44 (11.8–149.5) |
Anti CCP-Ab (U/mL), median (IQR) | 60.1 (4.0–373.1) |
Corticosteroid, n (%) | 53 (45.7) |
Methotrexate, n (%) | 59 (50.9) |
Biologics, n (%) | 38 (32.8) |
DAS28-ESR, median (IQR) | 2.8 (2.0–3.7) |
Steinbrocker stage | I: 35, II:40, III 26, IV 13 |